Graves' Ophthalmopathy - Pipeline Review, H1 2018

Publisher Name :
Date: 12-Jun-2018
No. of pages: 35
Inquire Before Buying

Graves' Ophthalmopathy - Pipeline Review, H1 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves' Ophthalmopathy - Pipeline Review, H1 2018, provides an overview of the Graves' Ophthalmopathy (Ophthalmology) pipeline landscape.

Graves' ophthalmopathy is an autoimmune condition where the thyroid gland mistakenly senses harmful cells and releases antibodies to combat them. Since there are no harmful cells, the released antibodies end up fusing with muscles in the eyes, causing the onset of Graves‘ophthalmopathy. Symptoms include eye redness, eye inflammation, eyelid retraction and eye weakness. Treatment includes radioiodine therapy, anti-thyroid medications and thyroid surgery.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Graves' Ophthalmopathy - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Graves' Ophthalmopathy (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Graves' Ophthalmopathy (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Graves' Ophthalmopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Preclinical stages are 1, 2 and 2 respectively.

Graves' Ophthalmopathy (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Graves' Ophthalmopathy (Ophthalmology).

- The pipeline guide reviews pipeline therapeutics for Graves' Ophthalmopathy (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Graves' Ophthalmopathy (Ophthalmology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Graves' Ophthalmopathy (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Graves' Ophthalmopathy (Ophthalmology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Graves' Ophthalmopathy (Ophthalmology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Graves' Ophthalmopathy (Ophthalmology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Graves' Ophthalmopathy - Pipeline Review, H1 2018

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Graves' Ophthalmopathy - Overview
Graves' Ophthalmopathy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Graves' Ophthalmopathy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Graves' Ophthalmopathy - Companies Involved in Therapeutics Development
Enceladus Pharmaceuticals BV
Genmab A/S
Novartis AG
Yuhan Corp
Graves' Ophthalmopathy - Drug Profiles
pasireotide ER - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
prednisolone sodium phosphate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
teprotumumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
YH-BIO - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
YH-NCE3 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Graves' Ophthalmopathy - Dormant Projects
Graves' Ophthalmopathy - Product Development Milestones
Featured News & Press Releases
Oct 25, 2017: Horizon Pharma Announces First Patient Enrolled in Confirmatory Phase 3 Clinical Trial Evaluating Teprotumumab for the Treatment of Moderate-to-Severe Active Thyroid Eye Disease
Jun 11, 2013: Genmab To Restart Clinical Development Of Teprotumumab In Phase II Study For Treatment Of Active Thyroid Eye Disease
Jun 11, 2013: River Vision Receives US Orphan Drug Designation For RV001 For Treatment Of Graves Orbitopathy
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Graves' Ophthalmopathy, H1 2018
Number of Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Graves' Ophthalmopathy - Pipeline by Enceladus Pharmaceuticals BV, H1 2018
Graves' Ophthalmopathy - Pipeline by Genmab A/S, H1 2018
Graves' Ophthalmopathy - Pipeline by Novartis AG, H1 2018
Graves' Ophthalmopathy - Pipeline by Yuhan Corp, H1 2018
Graves' Ophthalmopathy - Dormant Projects, H1 2018

List of Figures
Number of Products under Development for Graves' Ophthalmopathy, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products by Targets, H1 2018
Number of Products by Stage and Targets, H1 2018
Number of Products by Mechanism of Actions, H1 2018
Number of Products by Stage and Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Molecule Types, H1 2018
Number of Products by Stage and Molecule Types, H1 2018
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cancer Monoclonal Antibodies Market 2018, Forecast to 2023
    Published: 14-Dec-2018        Price: US 4880 Onwards        Pages: 119
    The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics. Scope of the Report: This report focuses on the Cancer Monoclonal Antibodies in global market, especially in North America, Europe and Asia-Pacific, Sou......
  • Global and Chinese Syphilis Rapid Test Kit Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 150
    The 'Global and Chinese Syphilis Rapid Test Kit Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Syphilis Rapid Test Kit industry with a focus on the Chinese market. The report provides key statistics on the market status of the Syphilis Rapid Test Kit manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the indu......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cervical Cancer Drugs Market 2018, Forecast to 2023
    Published: 14-Dec-2018        Price: US 4880 Onwards        Pages: 130
    Cervical cancer is an uncontrolled growth of cells in the cervix region, which is accompanied by symptoms such as abnormal vaginal bleeding, pelvic pain, pain during sexual intercourse, and abnormal vaginal discharge. Scope of the Report: This report focuses on the Cervical Cancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and ap......
  • Global and Chinese Human Growth Hormone Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Human Growth Hormone Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Human Growth Hormone industry with a focus on the Chinese market. The report provides key statistics on the market status of the Human Growth Hormone manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry incl......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Chlorpheniramine Maleate Market 2018, Forecast to 2023
    Published: 14-Dec-2018        Price: US 4880 Onwards        Pages: 128
    Chlorpheniramine maleate is an alkylamine antihistamine which is used in the treatment of allergic conditions such as rhinitis and urticaria. Scope of the Report: This report focuses on the Chlorpheniramine Maleate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. This compound blocks histamine during allergic reaction......
  • Global and Chinese Active Pharmaceutical Ingredients Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 146
    The 'Global and Chinese Active Pharmaceutical Ingredients Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Active Pharmaceutical Ingredients industry with a focus on the Chinese market. The report provides key statistics on the market status of the Active Pharmaceutical Ingredients manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provide......
  • Global and Chinese Acyclovir Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 149
    The 'Global and Chinese Acyclovir Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Acyclovir industry with a focus on the Chinese market. The report provides key statistics on the market status of the Acyclovir manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, application......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cetrimide Market 2018, Forecast to 2023
    Published: 14-Dec-2018        Price: US 4880 Onwards        Pages: 137
    Cetrimide is an antiseptic agent, meaning it has various antibacterial, antifungal and other antimicrobial properties and can be applied to skin or mucous membranes to avoid or minimize the risk of infection. It is also a surfactant, meaning it functions as a detergent with cleaning properties. Scope of the Report: This report focuses on the Cetrimide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ......
  • Global and Chinese Bone Glues Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 137
    The 'Global and Chinese Bone Glues Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Bone Glues industry with a focus on the Chinese market. The report provides key statistics on the market status of the Bone Glues manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, applicat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs